2022
DOI: 10.3390/vaccines10091423
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage

Abstract: The data on hepatitis A virus (HAV) seroprevalence are critical for the implementation of a universal mass vaccination (UMV) strategy. The latter has not been implemented in Russia; however, regional child vaccination programs have been adopted in some parts of the country. The aim of this study is to assess changes in HAV immunity within the last decade in regions of Russia with different vaccination strategies and different vaccination coverage rates. In regions where UMV has not been implemented and HAV vac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
7
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 21 publications
3
7
2
Order By: Relevance
“…In other study regions, the anti-HEV antibody detection rates either remained stable or increased slightly, indicating stable HEV circulation for at least the last 10–15 years. Such trends differ significantly from the decrease in the prevalence of antibodies to the hepatitis A virus (HAV) observed recently in the same regions of the country [ 38 ], highlighting fundamental differences in the risk factors and transmission routes of HAV and HEV in Russia. On the other hand, the results of the HEV population dynamics analysis indicate a decrease in the intensity of the virus’s circulation in Russia over the past 20 years, corresponding to an estimated decline in the global population size of HEV-3 over the last 20 years [ 39 ].…”
Section: Discussioncontrasting
confidence: 63%
“…In other study regions, the anti-HEV antibody detection rates either remained stable or increased slightly, indicating stable HEV circulation for at least the last 10–15 years. Such trends differ significantly from the decrease in the prevalence of antibodies to the hepatitis A virus (HAV) observed recently in the same regions of the country [ 38 ], highlighting fundamental differences in the risk factors and transmission routes of HAV and HEV in Russia. On the other hand, the results of the HEV population dynamics analysis indicate a decrease in the intensity of the virus’s circulation in Russia over the past 20 years, corresponding to an estimated decline in the global population size of HEV-3 over the last 20 years [ 39 ].…”
Section: Discussioncontrasting
confidence: 63%
“…The HAV seroprevalence above 50% in individuals aged over 15 years old in the studied cohort suggests an intermediate level of endemicity, according to the WHO classification [ 31 ]. Age-specific HAV seroprevalence rates observed in this study are similar to those obtained in the 2020 serosurvey that primarily targeted the urban population of Yakutia [ 32 ]. The significantly lower anti-HAV IgG detection rates in individuals aged under 40 years old compared to older age groups suggest the possible changes in HAV endemicity over the last few decades.…”
Section: Discussionsupporting
confidence: 81%
“…In other study regions, anti-HEV antibody detection rates either remained stable or increased slightly, indicating stable HEV circulation for at least the last 10-15 years. Such trends differ significantly from the decrease in the prevalence of antibodies to the hepatitis A virus (HAV) observed recently in the same regions of the country [38], highlighting fundamental differences in risk factors and transmission routes of HAV and HEV in Russia. On the other hand, the results of the HEV population dynamics analysis indicate a decrease in the intensity of the virus's circulation in Russia over the past 20 years, corresponding to an estimated decline in the global population size of HEV-3 over the last 20 years [39].…”
Section: Discussioncontrasting
confidence: 64%